Nanotechnology for CNS delivery of bio-therapeutic agents. - Wikidata - wikimedia - TriplyDB

Nanotechnology for CNS delivery of bio-therapeutic agents.

Nanotechnology for CNS delivery of bio-therapeutic agents.

http://www.wikidata.org/entity/Q38124859

about

Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines Central nervous system toxicity of metallic nanoparticles Application of dental nanomaterials: potential toxicity to the central nervous system Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity Analgesic efficacy and safety of DALDA peptide analog delivery to the brain using oil-in-water nanoemulsion formulation.CNS delivery and pharmacokinetic evaluations of DALDA analgesic peptide analog administered in Nano-sized oil-in-water emulsion formulation.Nano-enabled delivery of diverse payloads across complex biological barriers.Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides.Nanomaterial applications in multiple sclerosis inflamed brain.Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.Nano carriers for drug transport across the blood-brain barrier.Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method.

P2860

Q26783306-42349EB5-E16E-4155-813C-49EE537536E7 Q26850868-15CF2B22-DC20-4C5D-828B-EB1E653D93B2 Q28084729-A37F51EB-CCD0-4E1A-88DF-DA66995C362F Q28394487-05B06108-3D3C-445F-80B5-0D9D80CE9F96 Q28606583-9544DFD6-E74D-4137-BADE-6450BE3E08DA Q30813675-26E71DC1-13A5-4EEA-A2C4-9AB651BEB402 Q33573976-2250ECB0-BE7E-4CFA-BAA0-9BD77F4B0D78 Q36307467-6F2CD60A-1145-46DB-9FFE-8234846CD554 Q37698620-766C7771-FBA2-4577-B3D2-C1B505E00A15 Q38246688-ADD5768D-CBC4-4419-AC29-5E2369771E9D Q38330408-1A51425A-3EED-4516-B359-C860550E1195 Q38761724-F776651B-ED9F-43DA-9F49-671F283C4A4F Q38820474-44F37EBB-3EF3-45D3-A172-27C05C80C5E3 Q50867130-5ED6B37C-5555-4022-8E5F-A3562055F81A

P2860

Nanotechnology for CNS delivery of bio-therapeutic agents.

http://www.wikidata.org/entity/Q38124859

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nanotechnology for CNS delivery of bio-therapeutic agents.

@en

type

label

Nanotechnology for CNS delivery of bio-therapeutic agents.

@en

prefLabel

Nanotechnology for CNS delivery of bio-therapeutic agents.

@en

P1433

Q38124859-B9D5A51E-9EAE-409E-8084-AD8A00FF480A

P1476

Q38124859-F23CC3E8-6337-4AAD-B98A-121FBD3F7A06

P2093

Q38124859-19CD30C8-CE31-4F99-86A5-EFC55B33B1D9

Q38124859-3E947C18-36D7-4CA5-8BFE-6A8552390F5F

Q38124859-BEF1F60F-AE38-4E26-9204-5862F69EA1D3

P2860

Q38124859-07CD4342-64DF-416A-9A8B-597078B24EA5

Q38124859-0EA5FA1C-91DC-498B-9976-A604C5F33B63

Q38124859-0EB70034-2E6A-415E-B804-65FB7C1DB3A6

Q38124859-12DF2B47-676D-4A96-8E53-3F8D0E1F33BA

Q38124859-13517AA5-C42E-4EFA-80D5-C13FF5FB0976

Q38124859-157EC6F7-FBA3-428F-8C0D-34183D32792A

Q38124859-1643DDD1-667C-40E6-84F8-8274B7912AF0

Q38124859-1D9768A5-3B51-4580-A399-CEC52A06F87F

Q38124859-1EFE2096-962B-45A8-B201-8976BBE4F4EC

Q38124859-233A2AD7-2D21-46EA-9C28-3481C828E498

P2888

Q38124859-6C2862A2-7156-497B-A8CE-603CF3573F3B

P304

Q38124859-EE4B16CC-EF5E-45E2-9C9D-A5D8C4519024

P31

Q38124859-49AB3266-280C-4847-B2C5-7F638882B65E

P356

Q38124859-7F35C5BF-AFE3-4E34-884C-F725113368DF

P433

Q38124859-30290C10-9779-4E76-9DF1-DCFFC45EBD62

P478

Q38124859-036634D8-0D03-45AA-AB22-E6EDA3118DB0

P577

Q38124859-DFC13F03-35FE-4014-BD67-C33E672B97FC

P5875

Q38124859-4010672C-9FC6-428A-AD87-B081B65AC83B

P6179

Q38124859-74BACA3C-B9A2-44D2-ADCF-D64AE5B65D9B

P698

Q38124859-60D51C55-370B-49DF-BC7D-7F6626F22A5E

P921

Q38124859-FACB1DD9-E0A0-4666-A21F-84202EEBF1B5

P932

Q38124859-B35287F9-FB1A-4C5C-A5ED-3025FECD665A

P356

S13346-013-0133-3

P1433

Drug delivery and translational research

P1476

Nanotechnology for CNS delivery of bio-therapeutic agents.

@en

P2093

Lipa Shah

http://www.w3.org/2001/XMLSchema#string

Mansoor Amiji

http://www.w3.org/2001/XMLSchema#string

Sunita Yadav

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Astrocyte-endothelial interactions at the blood-brain barrier

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Improved selective, simple, and contrast staining of acidophilic neurons with vanadium acid fuchsin.

Transport of drugs from the nasal cavity to the central nervous system.

Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.

A review of nanocarrier-based CNS delivery systems.

Solid lipid nanoparticles for targeted brain drug delivery.

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

Sniffing neuropeptides: a transnasal approach to the human brain.

P2888

s13346-013-0133-3

P304

336-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13346-013-0133-3

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253336784

http://www.w3.org/2001/XMLSchema#string

P6179

1009330523

http://www.w3.org/2001/XMLSchema#string

P698

23894728

http://www.w3.org/2001/XMLSchema#string

P921

P932

3719983

http://www.w3.org/2001/XMLSchema#string